Loading…

Clinical Outcomes and Virulence Factors of Shiga Toxin-Producing Escherichia coli (STEC) from Southern Alberta, Canada, from 2020 to 2022

Shiga toxin-producing (STEC) can cause severe clinical disease in humans, particularly in young children. Recent advances have led to greater availability of sequencing technologies. We sought to use whole genome sequencing data to identify the presence or absence of known virulence factors in all c...

Full description

Saved in:
Bibliographic Details
Published in:Pathogens (Basel) 2024-09, Vol.13 (10), p.822
Main Authors: Glassman, Heather, Suttorp, Vivien, White, Theron, Ziebell, Kim, Kearney, Ashley, Bessonov, Kyrylo, Li, Vincent, Chui, Linda
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Shiga toxin-producing (STEC) can cause severe clinical disease in humans, particularly in young children. Recent advances have led to greater availability of sequencing technologies. We sought to use whole genome sequencing data to identify the presence or absence of known virulence factors in all clinical isolates submitted to our laboratory from Southern Alberta dated 2020-2022 and correlate these virulence factors with clinical outcomes obtained through chart review. Overall, the majority of HUS and hospitalizations were seen in patients with O157:H7 serotypes, and HUS cases were primarily in young children. The frequency of virulence factors differed between O157:H7 and non-O157 serotypes. Within the O157:H7 cases, certain virulence factors, including , , and , were more frequent in HUS cases. The number of samples was too low to determine statistical significance.
ISSN:2076-0817
2076-0817
DOI:10.3390/pathogens13100822